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It has been proposed that separase-dependent
centriole disengagement at anaphase licenses
centrosomes for duplication in the next cell cycle.
Here we test whether such a mechanism exists in
intact human cells. Loss of separase blocked cen-
triole disengagement during mitotic exit and delayed
assembly of new centrioles during the following S
phase; however, most engagements were eventually
dissolved. We identified Polo-like kinase 1 (Plk1) as a
parallel activator of centriole disengagement. Timed
inhibition of Plk1 mapped its critical period of action
to late G2 or early M phase, i.e., prior to securin
destruction and separase activation at anaphase
onset. Crucially, when cells exited mitosis after
downregulation of both separase and Plk1, centriole
disengagement failed completely, and subsequent
centriole duplication in interphase was also blocked.
Our results indicate that Plk1 and separase act at
different times duringMphase to license centrosome
duplication, reminiscent of their roles in removing
cohesin from chromosomes.
INTRODUCTION
The centrosome is the major microtubule organizing center
(MTOC) in most animal cells and strongly influences spindle
assembly duringmitosis (Luders and Stearns, 2007). As a conse-
quence, centrosome number must be precisely regulated to
ensure genome stability. During interphase, actively proliferating
cells contain two centrosomes that are juxtaposed to form a
single MTOC. Depending on the cell-cycle stage, the core of
each centrosome consists of either a single centriole, or a pair
of orthogonally opposed, or engaged, centrioles, surrounded
by pericentriolar material (PCM) that nucleates and organizes
microtubule arrays (Azimzadeh and Bornens, 2007; Betten-
court-Dias and Glover, 2007). Because centrioles dictate PCM
localization and thus determine the number of centrosomes,
from a mechanistic perspective, the problem of centrosome344 Developmental Cell 17, 344–354, September 15, 2009 ª2009 Elduplication resolves to the question of how centriole duplication
is controlled and coordinated with other cell-cycle events.
Cells begin G1 phase with two centrosomes that each contain
a single centriole. During S phase, a new (daughter) centriole
grows from the lateral surface of each pre-existing (mother)
centriole, due to the combined influence of Cdk2/cyclin E activity
and a conserved set of centriole assembly factors (Azimzadeh
and Bornens, 2007; Bettencourt-Dias and Glover, 2007; Nigg,
2007). Importantly, although this event doubles the number of
centrioles, each daughter centriole remains engaged with (and
shares the same PCM as) its mother. Thus, centriole duplication
per se does not cause an immediate change in the total number
of centrosomes. Rather, this occurs only upon passage through
mitosis and cytokinesis, when each centrosome associates with
one of the two spindle poles and is inherited by the correspond-
ing daughter cell. Around the same time, the paired centrioles
within each centrosome disengage (Kuriyama and Borisy,
1981), enabling the daughter centriole ultimately to acquire its
own PCM and form a new centrosome.
Beyond its temporal restriction to S phase, centriole duplica-
tion is also governed by centrosome-intrinsic mechanisms. For
example, in normal cells amother centriole producesonly a single
daughter centriole, regardless of the length of S phase (Wong and
Stearns, 2003). However, this restrictive control does not pre-
clude centriole duplication in G1 centrosomes that are exposed
to S or G2 phase cytoplasm via cell fusion (Wong and Stearns,
2003). Conversely, if the daughter centriole within an S phase
centrosome is intentionally destroyed, the mother centriole re-
gains its ability to produce a new daughter centriole (Loncarek
et al., 2008). Together, these findings suggest that the physical
engagement between mother and daughter centrioles creates
a cis-acting block to further rounds of centriole assembly that is
relieved only as cells pass through M phase, thereby entraining
centrosome duplication to the broader cell division cycle.
Despite its fundamental role in centrosome biology, centriole
disengagement remains poorly understood at the molecular
level. Whereas RNAi screens in nematodes, flies, and mamma-
lian tissue culture cells have uncovered multiple gene products
necessary for centriole duplication in S phase (Azimzadeh and
Bornens, 2007; Bettencourt-Dias and Glover, 2007; Nigg,
2007), none have thus far been identified which are required
for centriole disengagement during M phase exit. Nevertheless,sevier Inc.
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Plk1 and Separase License Centriole Growth In Vivorecent in vitro experiments implicate the mitotic protease sepa-
rase in this process (Tsou and Stearns, 2006b). This enzyme
becomes active at anaphase onset and triggers sister chromatid
disjunction via endoproteolytic cleavage of cohesin (Nasmyth,
2002), but also controls aspects of M phase exit via nonproteo-
lytic mechanisms (Gorr et al., 2006; Kudo et al., 2006; Stegmeier
et al., 2002; Sullivan and Uhlmann, 2003). Specifically, it was
observed that purified human centrosomes undergo anaphase-
specific disengagement when added to Xenopus egg extracts,
unless these extracts are first treated with high levels of nonde-
gradable cyclin B or securin, treatments known to inhibit sepa-
rase (Tsou and Stearns, 2006b).
While both securin and cyclin B clearly inhibit separase (Gorr
et al., 2005), whether separase is in fact their relevant target
vis-a`-vis centriole disengagement remains unsettled, as flies
and mice with hypomorphic or conditional separase alleles
lack obvious defects in centrosome duplication, and by implica-
tion, centriole disengagement (Kumada et al., 2006; Pandey
et al., 2005; Wirth et al., 2006). One possibility is that securin
and cyclin B both inhibit an additional component of the egg
extract that is distinct from separase. Alternatively, this discrep-
ancy could be explained by technical limitations in the rate or
completeness of separase inactivation in vivo, resulting in an
intermediate level of function that is inadequate for chromatid
disjunction but sufficient for centriole disengagement. A similar
situation has recently been described in budding yeast; temper-
ature-sensitive esp1 (separase) alleles that fully block cohesin
cleavage delay mitotic exit only slightly (Stegmeier et al., 2002;
Sullivan and Uhlmann, 2003), but if these alleles are genetically
engineered to enhance their thermolability, then both chromo-
some segregation and mitotic exit are blocked with high pene-
trance (Queralt et al., 2006), as also occurs in strains that express
nondegradable securin (Cohen-Fix and Koshland, 1999; Tinker-
Kulberg and Morgan, 1999). Finally, separase could be essential
for centriole disengagement only in meiotic cells or extracts, but
partially or completely rescued by a second disengagement
pathway in somatic cells. A similar redundancy has been sug-
gested to explain why separase is required for M phase exit in
oocytes but not mouse embryonic fibroblasts (MEFs) (Gorr
et al., 2006; Kudo et al., 2006).
To elucidate the mechanisms responsible for centriole disen-
gagement and replicative licensing in vivo, we engineered
human somatic cells with conditional null alleles of hESPL1
(the locus encoding hSeparase) so that the endogenous pro-
tease could be fully depleted. We also developed a correlated
time-lapse/immunofluorescence/electronmicroscopyassay that
allowed us to monitor the temporal coupling between centriole
disengagement and mitotic exit in individual cells. Using these
tools, we report that without separase, engaged centrioles are
no longer disengaged in synchrony with M phase exit, but
instead persist well into G1 phase. Centriole disengagement
requires the proteolytic activity of separase but is not affected
by overexpression of noncleavable cohesin, suggesting that
separase promotes disengagement through cleavage of an
additional noncohesin substrate. However, longer-term obser-
vation revealed that engaged centrioles are not completely
stable in cells lacking hSeparase, implying the existence of an
additional disengagement-promoting activity. Using highly
specific pharmacologic and chemical genetic inhibitors, weDevelopmeidentified Polo-like kinase 1 (Plk1) as a positive regulator of
centriole disengagement, and furthermapped its execution point
temporally to late G2 or early mitosis, upstream of securin
destruction and separase activation in anaphase. Combined
inactivation of both separase and Plk1 eliminated disengage-
ment, and most importantly, prevented cells from assembling
new centrioles upon entry into S phase. We conclude that Plk1
and separase act during M phase to license centrioles for dupli-
cation in the following cell cycle. Taken together, these results
provide a molecular description of the mechanism that limits
centrosome duplication to a single round per cell cycle in vivo.
RESULTS
To test the role of separase in centriole disengagement, we
wished to analyze cells with null mutations in the gene encoding
separase. Although mice with conditional mESPL1 alleles exist,
these alleles may permit the synthesis of fragments of mSepar-
ase that, although proteolytically inactive, retain some cell-cycle
regulatory functions (Kumada et al., 2006; Wirth et al., 2006). To
eliminate this potential caveat we targeted the gene encoding
the human enzyme, for which both N-terminal and C-terminal
antibodies exist (Chestukhin et al., 2003; Jallepalli et al., 2001;
Papi et al., 2005; Waizenegger et al., 2000). Briefly, HCT116 cells
(a diploid and karyotypically stable human colorectal cell line)
were sequentially infected with two adeno-associated virus
(AAV)-based gene-targeting vectors, such that exon 21 of the
hESPL1 locus was either flanked by loxP sites or deleted
outright (see Figure S1A available online). Three independent
hESPL1flox/D clones were derived in this manner and verified
by Southern blotting (Figure S1B).
To inactivate separase, hESPL1flox/D cells were infected with
an adenovirus expressing Cre recombinase (AdCre), or with an
adenovirus expressing b-galactosidase (Adbgal) as a negative
control. Within 48 hr of AdCre infection, both full-length hSepar-
ase (220 kDa) and its autocleavage fragments (160 kDa and
60 kDa) were lost, without the appearance of any new immuno-
reactive species (Figure 1A). Cytologically, homozygous deletion
of hESPL1 resulted in a severe block to anaphase chromosome
segregation, as judged by live imaging of cells expressing GFP-
tagged histone H2B (Movies S1 and S2) and immunofluores-
cence microscopy of fixed cells stained with antibodies to
centromere-specific autoantigens (CREST) and INCENP, which
dissociates from centromeres at anaphase onset (Figure 1B).
Despite failing anaphase, hESPL1D/D cells exited M phase
and progressed through further rounds of DNA replication, re-
sulting in polyploidy (Figure S1C) and the accumulation of
so-called ‘‘diplochromosomes’’ (sets of four cohesed sister
chromatids) by cytogenetic analysis (Figure S1D). Notably, this
chronic retention of chromosome cohesion occurred despite
timely loss of the cohesin protector Sgo1 from centromeres
(Figure 1B). In contrast, the Drosophila Sgo1 ortholog MeiS-
332 remains stably bound to anaphase centromeres in the
absence of separase (Lee et al., 2004). Based on these results,
we conclude that our conditional gene-targeting strategy elimi-
nates expression of all hSeparase-derived polypeptides and
blocks sister chromatid separation but not overall cell-cycle
progression, similar to mESPL1-deficient MEFs (Kumada et al.,
2006; Wirth et al., 2006).ntal Cell 17, 344–354, September 15, 2009 ª2009 Elsevier Inc. 345
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Plk1 and Separase License Centriole Growth In VivoFigure 1. hSeparase Is Essential for
Centriole Disengagement during M Phase
Exit
(A) Homozygous deletion of hESPL1 generates
cells devoid of hSeparase-derived polypeptides.
hESPL1flox/D cells were generated by homologous
recombination (FigureS1) and infectedwithadeno-
viruses expressing Cre recombinase (AdCre) or
b-galactosidase (Adbgal) as a negative control.
Cells were harvested at the indicated times postin-
fection and analyzed by immunoblotting. Bands
corresponding to full-length hSeparase (FL) and
auto-cleaved N- and C-terminal fragments (N and
C) are highlighted with arrowheads.
(B) hESPL1flox/D cells in metaphase and anaphase
(top two rows) and hESPL1D/D cells (48 hr after
AdCre infection) undergoing nondisjunction in
anaphase (NDJ, bottom row) were stained with
antibodies to INCENP (yellow), CREST antiserum
(green), and Sgo1 (red).
(C and D) hESPL1flox/D cells infected with Adbgal
(C) or AdCre (D) were traced by time-lapse micros-
copy. After fixation and staining, cells that had
exited mitosis 2.5–6 hr earlier were relocated and
scored for centriole engagement with anti-centrin
(green) and anti-C-Nap1 (red) antibodies. Nuclei
were visualized with DAPI (blue).
(E) Quantification of (C) and (D). Error bars indicate
standard deviations from three independent
experiments.
(F) A hESPL1D/D cell was traced through M phase
exit by time-lapsemicroscopy, permeabilized, and
stained with anti-centrin and anti-C-Nap1 anti-
bodies. Arrow and arrowhead indicate centrioles
and centrin aggregates, respectively. After acquir-
ing fluorescent images, the same cell was fixed
and processed for electron microscopy. Electron
micrographs are shown at three different magnifi-
cations to facilitate correlation between images
and visualization of centriolar structures. Box 1
highlights two consecutive sections of an elec-
tron-dense centrin aggregate; Box 2, two pairs of
engaged centrioles.We next used this system to address hSeparase’s role in
centriole disengagement. We developed a correlated time-
lapse/immunofluorescence microscopy assay for analyzing
both centriole configuration and cell-cycle position in individual
cells (Figures 1C–1E). Briefly, hESPL1flox/D cells were plated
onto gridded coverslips and infected with AdCre or Adbgal as
above. Beginning 40 hr after infection, coverslips were imaged
by phase-contrast microscopy for 12 hr to identify cells entering
and exiting mitosis, then fixed and stained with antibodies to
centrin and C-Nap1, which differentially mark engaged versus
disengaged centrioles (Tsou and Stearns, 2006b). From the
time-lapse recordings, cells that had exited mitosis 2.5–6 hr
earlier, and thus were in G1 phase at the time of fixation, were
identified. These cells were relocated on the coverslip and
scored for their pattern of centrin and C-Nap1 staining. Ninety-
three percent of Adbgal-infected hESPL1flox/D cells exhibited
a 1:1 ratio of centrin and C-Nap1 foci in each G1-phase daughter
cell (Figures 1C and 1E), indicating successful centriole disen-
gagement. In contrast, 81% of AdCre-infected cells that
reached G1 after anaphase failure exhibited a G2-like centriole346 Developmental Cell 17, 344–354, September 15, 2009 ª2009 Elpattern, with four centrin foci and two C-Nap1 foci (a 2:1 ratio;
Figures 1D and 1E). To confirm that these centrioles were
engaged, we performed correlated time-lapse/immunofluores-
cence/electron microscopy (Figure 1F). hESPL1D/D cells that
had exited mitosis 4–6 hr earlier were located and immuno-
stained with antibodies to centrin and C-Nap1. After acquisition
of fluorescent signals, the same cell was further fixed and
processed for transmission electron microscopy (n = 4). Both
pairs of centrioles in each of these cells were engaged (i.e., in
an orthogonal configuration; Figure 1F), in agreement with the
localization of centrin and C-Nap1 by light microscopy. We
also occasionally observed additional centrin-containing aggre-
gates of variable size in the cytoplasm (Figure S2). The nature of
these aggregates is not known, but they lack typical microtubule
structures that define centrioles (Figure S2 and Figure 1F, Box
1a and 1b). In addition, although centrin is enriched in these
structures, the centriolar proteins pericentrin, HsSas-6, and
C-Nap1 are absent (data not shown). These data demonstrate
that hSeparase is needed for centriole pairs to disengage
in vivo after M phase exit.sevier Inc.
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could reflect a direct positive requirement for separase, or an
indirect negative effect of anaphase failure. To distinguish
between these two alternatives, we analyzed the centrioles of
cells that express a noncleavable form of the cohesin subunit
Scc1 (Scc1NC) under the control of a tetracycline-regulated
promoter (Hauf et al., 2001). We again used correlative time-
lapsemicroscopy and focused our analysis on the most severely
affected population of Scc1NC cells (5% of the total) in which
anaphase chromatid disjunction failed completely, giving rise
to a cell with a single undivided nucleus (Figure 2A). All cells
examined (n = 9) exhibited 1:1 ratios of centrin andC-Nap1 stain-
ing, indicating that centriole disengagement does not depend on
successful anaphase chromosome segregation. Thus, the
absence of chromatid disjunction cannot explain the failure of
centriole disengagement in hESPL1D/D cells. Rather, it appears
that hSeparase triggers both events in parallel during M phase
exit.
In both yeast and vertebrate oocytes, separase functions
other than cohesin destruction do not depend on its cysteine
protease activity, but are nonetheless sensitive to inhibition by
securin (Gorr et al., 2005; Herbert et al., 2003; Kudo et al.,
2006; Stegmeier et al., 2002; Sullivan and Uhlmann, 2003). To
address whether centriole disengagement requires separase’s
protease activity, hESPL1flox/D cells were stably transfected
with constructs that direct Cre-dependent expression of FLAG
epitope-tagged wild-type (WT) or protease-dead (C2029S)
hSeparase (Figure 2B). In these cells, endogenous hSeparase
disappeared upon AdCre infection, and the transgene-encoded
proteins were induced (Figure 2C). As expected, protease-dead
hSeparaseCS failed to rescue the chromosome segregation
defect of hESPL1D/D cells, in contrast to hSeparaseWT (Fig-
ure 2D). hSeparaseCS was also unable to rescue the centriole
disengagement defect of hESPL1D/D cells (Figures 2E–2G).
These data indicate that the cysteine protease activity of hSepar-
ase is required to separate sister chromatids and disengage
centriole pairs at mitotic exit.
Having established that hSeparase-mediated proteolysis is
important for centriole disengagement in vivo, we next investi-
gated the fate of centriole pairs that remain engaged in its
absence. We filmed hESPL1D/D cells for longer periods, during
which we included a 1 hr pulse-labeling with 5-bromo-2-deoxy-
uridine (BrdU) and a 4–5 hr BrdU-free chase to mark cells
progressing through S phase (Figure 3A). Both hESPL1flox/D
and hESPL1D/D cells entered S phase about 7 hr after mitosis
(data not shown). As expected, more than 90% of the previously
disengaged centrioles in control hESPL1flox/D cells underwent
duplication, resulting in two pairs of engaged centrioles (i.e.,
four centrin foci and two C-Nap1 foci per cell; Figure 3B). In
contrast, hESPL1D/D cells displayed a wide range of aberrant
centriole configurations that reflected a significant but variable
block to duplication. Seventeen percent of cells exhibited the
strongest phenotype, wherein only the two pairs of engaged
centrioles inherited from the previous mitosis and failed cell divi-
sion were present (four centrin foci and two C-Nap1 foci per cell;
Figures 3C and 3F). However, we noticed that the C-Nap1 focus
in some centriole pairs was elongated (Figure 3C), rather than
a compact dot as seen in G1 phase (Figures 1D and 1F), sug-
gesting that these juxtaposed centrioles were actually in an earlyDevelopmestage of disengagement. Consistent with this interpretation, the
majority (53%) of cells displayed five to six centrin foci and three
C-Nap1 foci (Figures 3D and 3F), indicating that one of the two
centriole pairs had overtly disengaged and duplicated. Such
asynchronous duplication was never observed in control cells.
In the remaining 30%, full centriole disengagement and duplica-
tion were evident (Figures 3E and 3F). These results indicate that
hSeparase is essential for the telophase-specific dissolution of
centriole engagement, and probably as a consequence, for the
timely and synchronous assembly of new centrioles in S phase.
However, it also appears thatmammalian cells possess a second
activity that can disengage centrioles, albeit inefficiently, when
hSeparase is absent or limiting.
Separase does not dissolve sister chromatid cohesion in isola-
tion, but rather is assisted by Polo-like kinase 1 (Plk1)-dependent
phosphorylation. For example, Plk1-generated modifications on
the SA2 subunit of cohesin promote the complex’s nonproteo-
lytic removal from chromosome arms in prophase (Hauf et al.,
2005; Sumara et al., 2002), while similar modifications on Scc1
or its meiotic counterpart Rec8 drive anaphase-specific cohesin
destruction, apparently by making Scc1 and Rec8 better sub-
strates for separase (Alexandru et al., 2001; Brar et al., 2006;
Hauf et al., 2005; Hornig and Uhlmann, 2004). Plk1 also localizes
to centrosomes and is a key regulator of their structure and
MTOC activity during spindle assembly (Barr et al., 2004;
Petronczki et al., 2008). We therefore considered Plk1 a
candidate for the second disengagement-promoting activity in
mammalian cells.
To test this hypothesis, we rapidly inactivated Plk1 using
specific small-molecule inhibitors. First, we treated hESPL1flox/D
cells with BI 2536 (hereafter BI) specifically during late mitosis
(Figure 4A, top panel). In agreement with recent reports (Brennan
et al., 2007; Burkard et al., 2007; Petronczki et al., 2007; Santa-
maria et al., 2007), inhibiting Plk1 in this manner allowed mitotic
exit but prevented cytokinesis, resulting in binucleated inter-
phase cells. Nevertheless, centriole disengagement and dupli-
cation proceeded on schedule in the next cell cycle, indicating
that the late mitotic activity of Plk1 is not needed for these
aspects of centriole metabolism (Figures 4B and 4G). In compar-
ison, we observed a quite different result when Plk1 was in-
hibited earlier, in late G2 or early M phase. Briefly, we filmed
an asynchronous culture of hESPL1flox/D cells treated with BI
for 3 hr, during which time some cells entered mitosis but
arrested in prometaphase with monopolar spindles, as expected
(Lenart et al., 2007). These cells were then induced to exit mitosis
by treatment with the Cdk1-specific inhibitor RO-3306 (Vassilev
et al., 2006; hereafter RO) and pulse-labeled with BrdU as above
(Figure 4A, bottom panel). Inhibiting Cdk1 in this manner allows
cells to exit mitosis and carry out the subsequent round of DNA
replication. In contrast to late mitotic Plk1 inhibition, early M
phase Plk1 inhibition resulted in a dose-dependent block to
centriole disengagement and duplication in S phase (Figures
4C and 4F). For example, about one-third (37%) of cells treated
with 25 nM BI failed to disengage their centrioles, whereas an
8-fold higher dose (200 nM) blocked disengagement almost
completely (Figure 4G). To control for the possibility that mono-
polar spindle geometry indirectly perturbs centriole disengage-
ment, we analyzed centrioles in cells sequentially treated with
the Eg5 inhibitor monastrol and RO. Over 90% of all centriolesntal Cell 17, 344–354, September 15, 2009 ª2009 Elsevier Inc. 347
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Plk1 and Separase License Centriole Growth In VivoFigure 3. Many Centrioles Eventually Disengage and Duplicate in hESPL1Null Cells, Revealing the Existence of a Second Licensing Pathway
(A) Experimental scheme. Asynchronous hESPL1flox/D cells were infected with Adbgal or AdCre and traced by time-lapse microscopy. Cells that had exited
mitosis and progressed through the G1/S transition were labeled by a 1 hr BrdU pulse, followed by a 4 hr chase into BrdU-free medium. Cells were then fixed
and stained with antibodies to centrin, C-Nap1, and BrdU, and then examined for evidence of centriole disengagement and/or duplication in S phase.
(B) A pair of hESPL1flox/D cells exhibiting complete centriole disengagement (two C-Nap1 foci) and duplication (four centrin foci).
(C–E) Centriole configurations in hESPL1D/D cells.
(C) Absent or incipient centriole disengagement (two C-Nap1 foci) without duplication (four centrin foci).
(D) Asynchronous disengagement (three C-Nap1 foci) and duplication (five or six centrin foci).
(E) Complete disengagement (four C-Nap1 foci) and duplication (eight centrin foci).
(F) Quantification of S/G2 phase centriole configurations. Error bars indicate standard deviations from three independent experiments.disengaged and duplicated under these conditions (Figures 4E
and 4F), indicating that neither spindle bipolarity nor sponta-
neous relief of the spindle assembly checkpoint are required
for centrosome duplication.
Although BI has been developed as a Plk1-specific inhibitor,
this compound inhibits multiple Plks and could have additional
off-target effects. We therefore sought an independent andDevelopmegene-specific test of Plk1’s role in centriole disengagement. To
this end, we repeated the above experiments with a recently
described ‘‘chemical genetic’’ system for inhibiting Plk1 in
human retinal pigment epithelial cells (Burkard et al., 2007). In
this system, cells whose endogenous PLK1 gene has been
deleted via homologous recombination are complemented by
a genetically modified allele (Plk1as) whose ATP-binding pocketFigure 2. Centriole Disengagement Requires hSeparase-Mediated Proteolysis but Not Sister Chromatid Disjunction
(A) HeLa cells expressing noncleavable Scc1 (Scc1NC) from a tetracycline-regulated promoter were analyzed by correlative time-lapse immunofluorescence
microscopy as in Figure 1. Top and bottom rows display disengaged centrioles in two different focal planes.
(B) Strategy for Cre recombinase-dependent expression of hSeparase transgenes.
(C) hESPL1flox/D cells harboring the indicated transgenes were infected with AdCre or Adbgal and analyzed by immunoblotting with a monoclonal antibody
specific for the C terminus of hSeparase. Asterisks denote breakdown products. Tubulin was used to confirm equal loading.
(D) Cells in (C) were analyzed by flow cytometry 96 hr after AdCre infection. Peaks corresponding to diploid (2N), tetraploid (4N), octoploid (8N), and hexadeca-
ploid (16N) DNA content are indicated.
(E and F) hESPL1D /D cells expressing wild-type (WT) or protease-dead (CS) separase were examined by correlated time-lapse immunofluorescence microscopy
as in (A).
(G) Quantification of (E) and (F). Error bars indicate standard deviations from three independent experiments.ntal Cell 17, 344–354, September 15, 2009 ª2009 Elsevier Inc. 349
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Plk1 and Separase License Centriole Growth In VivoFigure 4. Plk1 Acts during Early Mitosis to Promote Centriole Disengagement
(A) Experimental scheme. Asynchronously proliferating cells were filmed during a 3 hr treatment with the Plk1 inhibitor BI-2536 (BI) or the Eg5 inhibitor monastrol
as a control. We note that Plk1 inactivation in late G2 or prophase activates the spindle assembly checkpoint and arrests cells in prometaphase. In contrast, late
mitotic Plk1 inactivation does not block anaphase onset, but instead inhibits cytokinesis. To allow analysis of centriole duplication potential under both treatment
regimens, cells in the former population were induced to exit mitosis using the Cdk1-selective inhibitor RO-3306 (RO). Cells transiting through S phase were
marked by BrdU pulse-labeling and analyzed as in Figure 3.
(B) A hESPL1flox/D cell treated with BI during late M phase (200 nM) exhibits complete centriole disengagement (four C-Nap1 foci) and duplication (eight
centrin foci).
(C) A hESPL1flox/D cell treated with BI during late G2 (200 nM), showing no disengagement (two C-Nap1 foci) and no duplication (four centrin foci).
(D) A Plk1as cell (RPE1, retinal pigment epithelial human cells) treatedwith 3MB-PP1 (10mM) during late G2, showing no disengagement (two C-Nap1 foci) and no
duplication (four centrin foci).
(E) A hESPL1flox/D cell treated withmonastrol (50 mM) during late G2 exhibits complete disengagement (four C-Nap1 foci) and duplication (eight centrin foci, one of
which lies in a different focal plane [data not shown]).
(F) Quantification of results in (B–E). Error bars indicate standard deviations from three independent experiments.can accommodate (and be inhibited by) bulky purine analogs.
Importantly, these analogs are inactive toward isogenic cells
lacking the Plk1as allele, providing evidence of their in vivo spec-
ificity (Burkard et al., 2007). Sequential treatment of Plk1as cells
with one such analog (3-MB-PP1) and RO dramatically inhibited
centriole disengagement and duplication (Figures 4D and 4F).
Together, these findings indicate that the activation of Plk1 at
centrosomes in late G2 or early M phase primes the dissolution
of centriole engagement in late M phase, and thus plays a crucial
role in licensing centriole duplication in S phase.350 Developmental Cell 17, 344–354, September 15, 2009 ª2009 ElsWe then returned to the issue of whether Plk1 potentiates the
eventual disengagement and duplication of centrioles in
hESPL1D/D cells. To address this question, we treated
hESPL1D/D cells with a low dose of BI (25 nM) during late G2
and early mitosis, and then induced mitotic exit with RO as
above. Strikingly, combined downregulation of Plk1 and
hSeparase exhibited a synergistic effect as compared with
either manipulation alone, as more than 95% of all centrioles
failed to disengage and duplicate under these conditions
(Figures 5A and 5B). These results strongly suggest that bothevier Inc.
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Plk1 and Separase License Centriole Growth In VivoPlk1 and separase play important roles in licensing centrioles for
duplication.
To strengthen this conclusion, we performed correlated time-
lapse/immunofluorescence/electron microscopy studies to con-
firm the defects of centriole disengagement and duplication
observed in these cells. G1 phase hESPL1flox/D or hESPL1D/D
cells (obtained by sequential treatment with high or low doses
of BI [200 or 25 nM] and RO in the previous cell cycle) were
stained with centrin and C-Nap1 (Figures 5C and 5D). After
acquiring fluorescent images the same cell was fixed,
embedded, and serially sectioned (Figures 5C and 5D). Consis-
tent with the IF pattern, centrioles in these cells were confirmed
to be engaged at the ultrastructural level (Figures 5C and 5D;
n = 3 for each case). Thus, centrin and C-Nap1 are reliable
markers of centriole configuration under these conditions. To
confirm and extend these results, S phase hESPL1flox/D cells
(treated with 200 nM BI in the previous G2/M phase) were also
subjected to correlative EM analysis (n = 5). One representative
is shown in Figure 5E. As anticipated from the IF pattern, only
four engaged centrioles were recovered from the serial sections
(Figure 5E), indicating that both centriole disengagement and
Figure 5. Separase and Plk1 Regulate the
Mitotic Licensing of Centriole Duplication
(A) G2 phase hESPL1D/D cells were treated with 25
nM BI, induced to exit mitosis with RO, and
labeled during S phase transit with BrdU. Centri-
oles remained engaged (two C-Nap1 foci) and
unable to duplicate (four centrin foci).
(B) Quantification of centriole duplication after
downregulation of hSeparase, Plk1, or both regu-
lators. Error bars indicate standard deviations
from three independent experiments.
(C andD)G2phase hESPL1D/D (C) and hESPL1flox/D
(D) cells were treated with BI 200 nM or 25 nM,
respectively, induced to exit mitosis with RO, and
stained with antibodies to centrin and C-Nap1.
Each cell was then processed for serial sectioning
and electron microscopy.
(E) A late S/G2 phase hESPL1flox/D cell treatedwith
BI 200 nM in the previous G2/Mphasewas stained
with antibodies to centrin, C-Nap1, and BrdU, and
then serially sectioned. Electron micrographs are
shown at three different magnifications to facilitate
correlation between images and details of
centriole structure (arrowheads).
duplication were blocked. Taken to-
gether, our findings reveal that Plk1 and
separase act during M phase to disen-
gage and license centrioles for duplica-
tion in the following cell cycle.
DISCUSSION
Like chromosomes, centrosomes dupli-
cate exactly once per cell cycle, but
how such regulation is achieved in
molecular terms has long been elusive.
One attractive hypothesis is that the
orthogonal configuration of duplicated
centrioles (termed ‘‘centriole engagement’’) plays a central role
in preventing centriole overduplication (Tsou and Stearns,
2006a). According to this model, centriole engagement, which
is first established during procentriole formation in S phase,
suppresses further assembly by sequestering or inhibiting one
or more activities that are rate-limiting for centriole duplication.
Because centriole engagement persists throughout S, G2, and
early M phase, this block would be relieved (or equivalently, a
new ‘‘license’’ to duplicate granted) only at M phase exit, when
centrioles disengage.
This hypothesis gained support from studies in Xenopus egg
extracts treated with nondegradable inhibitors of separase, a
cysteine protease that becomes active at anaphase onset and
known to cleave chromosome-bound cohesin rings (Tsou and
Stearns, 2006b). However, given the indirect nature of these
experiments, it could not be excluded that these inhibitors actu-
ally worked by targeting other components of the extract, espe-
cially as Drosophila embryos and MEFs deficient in separase
reportedly duplicate their centrosomes correctly. Furthermore,
it was unknown if centrioles that have passed through mitosis
but never been exposed to separase in fact fail to duplicate.Developmental Cell 17, 344–354, September 15, 2009 ª2009 Elsevier Inc. 351
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and extend this hypothesis by directly examining the fate of
centrioles in cells devoid of all detectable hSeparase. To do
this, we mutated both alleles of the gene encoding hSeparase
in human tissue culture cells and confirmed that these mutations
in fact eliminated expression of this large (220 kDa) protease,
rather than allowing continued synthesis of a truncated and
potentially bioactive N-terminal fragment. Homozygous inactiva-
tion of hSeparase strongly inhibited disengagement in the short
term (over a period of 2–6 hr after mitosis), after which approxi-
mately 50% of all centriole pairs disengaged and duplicated
during S phase. A similar dose-dependent inhibition of disen-
gagement was observed in cells treated with the Plk1 inhibitor
BI 2536 before (but not after) anaphase onset, indicating that
Plk1 promotes disengagement at a step prior to securin destruc-
tion and separase activation. However, combined downregula-
tion of both Plk1 and hSeparase resulted in a tight block to
centriole disengagement in telophase, and probably as a conse-
quence, complete suppression of centriole assembly in the next
S phase. Taken together, these results provide in vivo evidence
for the mitotic licensing of centriole duplication and, moreover,
link this licensing to the action of Plk1 and hSeparase during
early and late M phase, respectively.
A key question is how Plk1 and hSeparase act to coordinate
centriole disengagement with mitotic exit. By analogy to sister
chromatid cohesion, Plk1 could promote hSeparase-indepen-
dent removal of a centriolar ‘‘glue’’ protein in prophase and/or
facilitate anaphase-specific cleavage of this ‘‘glue’’ protein by
trace amounts of hSeparase that had not yet been cleared from
the cell after hESPL1 deletion. It was recently proposed that
the telophase/G1-specific destruction of HsSAS-6 (an essential
centriole assembly factor present at the mother-daughter inter-
face) also regulates the licensing of centriole duplication (Strnad
et al., 2007).While Plk1 inhibition stabilizedHsSAS-6 on engaged
centrioles, expressing nondegradable HsSAS-6 did not interfere
with centriole disengagement (data not shown), arguing that
HsSAS-6 destruction does not regulate this decision. Clearly,
further progress in this area will require identification of Plk1’s
and hSeparase’s disengagement-specific substrates and
detailed analysis of their regulation in the presence or absence
of these enzymes. Although the proteomic analysis of the centro-
some has been quite difficult due to its small size and low copy
number (Andersen et al., 2003), recent advances in the selective
labeling of cleaved protease substrates (Mahrus et al., 2008) and
kinase substrates (Allen et al., 2007; Blethrow et al., 2008) should
be quite helpful in this regard.
In summary, we have described a mechanism for the once-
and-only control of centrosome duplication in human cells,
whereby the growth of new centrioles in S phase crucially
depends on the Plk1- and hSeparase-dependent disengage-
ment of centriole pairs during the preceding M phase. Intrigu-
ingly, many aneuploid cancer cells exhibit both centrosome
amplification andmarked overexpression of Plk1 and hSeparase
(Carter et al., 2006; Strebhardt and Ullrich, 2006), raising the
question of whether such amplification could in some instances
be a consequence of precocious centriole disengagement,
rather than cytokinesis failure and subsequent tetraploidization,
or simultaneous assembly of multiple daughter centrioles in a
single S phase.352 Developmental Cell 17, 344–354, September 15, 2009 ª2009 ElEXPERIMENTAL PROCEDURES
Gene Targeting and Conditional Transgenesis
A BAC clone containing the human ESPL1 locus (RP11-680A11) was obtained
from BACPAC Resources (Children’s Hospital of Oakland Research Institute)
and used to amplify 50 and 30 homology arms via PCR. A loxP site and BglII
restriction-site polymorphism were introduced into the 30 element via Quik-
Change mutagenesis (Stratagene). Both homology arms were then cloned
into pNX, a pBluescript derivative that contains a central loxP-neo-loxP
cassette. The final targeting vector was sequenced in its entirety and then
transferred as a NotI fragment into pAAV, yielding pAAV-hESPL1flox. Produc-
tion of rAAV particles, infection of HCT116 cells, and genomic PCR screening
was carried out as described (Papi et al., 2005). hESPL1flox/+ cells were tar-
geted with a second rAAV vector in which exon 21 of hESPL1 was deleted,
yielding hESPL1flox/D cells. CsCl gradient-purified adenoviruses expressing
b-galactosidase (Adbgal) and Cre recombinase (AdCre) were purchased
from the Baylor University Vector Development Laboratory and used at amulti-
plicity of infection (MOI) of 25 plaque-forming units (pfu) per cell. To express
hSeparase in trans, FLAG-epitope tagged versions of hSeparase were cloned
into pCLIP (George et al., 2007) and stably transfected into hESPL1flox/D cells.
Transgene expression was activated by AdCre infection as described above.
Cell Culture, Drug Treatments, and Time-Lapse Microscopy
HCT116 cells were grown in McCoy’s 5A containing 10% fetal bovine serum
and 1% penicillin-streptomycin. Human telomerase-immortalized retinal
pigment epithelial (hTERT-RPE) cellswere cultured inDMEM:F-12 (1:1)medium
supplemented with 10% FBS and 1% penicillin-streptomycin. HeLa cells were
grown in DMEM supplemented with 10% fetal bovine serum and 1%penicillin-
streptomycin. Where indicated, BI 2536 (25 or 200 nM), monastrol (50 mM), and
RO-3306 (10 mM)were used. For correlative time-lapse experiments, cells were
imagedon a Zeiss Axiovert microscope configuredwith a 103 phase objective,
motorized temperature-controlled stage, environmental chamber, and CO2
enrichment system (Zeiss, Germany). Image acquisition and processing were
performed using Axiovision software (Zeiss, Germany). Sixty fields of cells
were filmed with 23 2 binning during each experiment. For time-lapse fluores-
cence microscopy, hESPL1flox/D cells were stably transfected with a histone
H2B-GFP expression plasmid (Kanda et al., 1998) and viewed on a Nikon
TE2000microscope outfitted with 103, 203, and 403 objectives, Hamamatsu
ORCA ER camera, and temperature-controlled stage enclosure and CO2
enrichment system (Solent Scientific). Image acquisition and processing were
performed using Metamorph software (Molecular Devices).
Antibodies
A rabbit polyclonal antibody against human C-Nap1 was produced as previ-
ously described (Mayor et al., 2000) and used at 1:500 dilution. Other
antibodies used in this study include mouse anti-centrin (20H5; a gift from
J. Salisbury, Mayo Clinic, Rochester, MN; 1:1000); mouse anti-INCENP
(Upstate; 1:500), mouse anti-Sgo1 (Novus; 1:500), rat anti-a-tubulin (Chemi-
con; 1:500), rat anti-BrdU (Novus; 1:500), mouse anti-hSeparase N terminus
(18H1; MSKCC Monoclonal Antibody Facility; 1:1000) and C terminus (XJ11-
1B12; Dana-Farber Cancer Institute Monoclonal Antibody Facility; 1:1000),
and human CREST antiserum (Immunovision; 1:1000). We note that some
commercial preparations of XJ11-1B12 predominantly contained antibodies
to proteins other than hSeparase, necessitating reisolation of the hybridoma
by the originating facility (Chestukhin et al., 2003).
Immunofluorescence Microscopy
Cells were fixed with methanol at 20C, then blocked with 3% bovine serum
albumin (w/v) and 0.1% Triton X-100 in PBS for 30 min. DNA was visualized
using 40,6-diamidino-2-phenylindole (DAPI; Molecular Probes). For visualizing
replicated DNA, BrdU (20 mM) was added to the cells as a 1 hr pulse. After
staining for centrosomal antigens, cells were fixed again with20Cmethanol
for 10 min and treated with 2 N HCl for 30 min at room temperature. Detection
of BrdU-positive cells was performed as above.
Electron Microscopy
Cells were traced by phase-contrast microscopy on gridded coverslips made
of ACLAR film (EM Sciences), permeabilized in PIPES buffer (pH 6.8)sevier Inc.
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as described above, and then fixed in modified Karnovsky’s fixative (Murphy
et al., 2000) consisting of 4% paraformaldehyde and 2.5% glutaraldehyde in
0.1 M phosphate buffer. For BrdU visualization, fixed cells were treated with
2 N HCl for 30 min at room temperature before staining for BrdU. After acqui-
sition of fluorescence images, cells were maintained on coverslips and further
processed for electron microscopy. Cells were first dehydrated in graded
series of ethanol, infiltrated with EMbed812 resin and embedded between
two ACLAR films. An area of coverslip containing the cells of interest was
selected based on the time-lapse movies, excised, and glued to the top of
an empty resin block. Mounted samples were sectioned (80–90 nm thickness)
on an Ultracut UC6 microtome. Sections were stained with 2% uranyl acetate
followed by 1% lead citrate and observed on a FEI TECNAI Spirit G2 micro-
scope. Electron micrographs were captured with the Gatan digital imaging
system.
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